| Ident. | Authors (with country if any) | Title |
|---|
| 000029 |
Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine] | [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus]. |
| 000032 |
Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine] | [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking]. |
| 000035 |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000050 |
Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine] | [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019]. |
| 000062 |
Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000100 |
Chang-Quan Ling | Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) |
| 000101 |
Yang Yang ; Md Sahidul Islam ; Jin Wang ; Yuan Li ; Xin Chen | Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective |
| 000104 |
Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis] | Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond. |
| 000108 |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000110 |
Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
| 000125 |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
| 000126 |
Carlo Contini [Italie] ; Mariachiara Di Nuzzo [Italie] ; Nicole Barp [Italie] ; Aurora Bonazza [Italie] ; Roberto De Giorgio [Italie] ; Mauro Tognon [Italie] ; Salvatore Rubino [Italie] | The novel zoonotic COVID-19 pandemic: An expected global health concern. |
| 000143 |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
| 000144 |
Wenzheng Han [République populaire de Chine] ; Bin Quan [République populaire de Chine] ; Yi Guo [République populaire de Chine] ; Jun Zhang [République populaire de Chine] ; Yong Lu [République populaire de Chine] ; Gang Feng [République populaire de Chine] ; Qiwen Wu [République populaire de Chine] ; Fang Fang [République populaire de Chine] ; Long Cheng [République populaire de Chine] ; Nanlin Jiao [République populaire de Chine] ; Xiaoning Li [République populaire de Chine] ; Qing Chen [République populaire de Chine] | The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. |
| 000166 |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
| 000184 |
Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine] | Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 |
| 000218 |
Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
| 000258 |
Jun Zheng [République populaire de Chine] | SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat |
| 000316 |
Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. |
| 000321 |
Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie] | Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
| 000352 |
Martina Ferioli [Italie] ; Cecilia Cisternino [Italie] ; Valentina Leo [Italie] ; Lara Pisani [Italie] ; Paolo Palange [Italie] ; Stefano Nava [Italie] | Protecting healthcare workers from SARS-CoV-2 infection: practical indications |
| 000356 |
Emmie De Wit ; Friederike Feldmann ; Jacqueline Cronin ; Robert Jordan ; Atsushi Okumura ; Tina Thomas ; Dana Scott ; Tomas Cihlar ; Heinz Feldmann | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection |
| 000380 |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000391 |
Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
| 000418 |
Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande] | Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). |
| 000430 |
Juan Simon Rico-Mesa [États-Unis] ; Averi White [États-Unis] ; Allen S. Anderson [États-Unis] | Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB |
| 000458 |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
| 000463 |
Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000474 |
Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie] | Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs. |
| 000511 |
Jared S. Morse ; Tyler Lalonde ; Shiqing Xu ; Wenshe Ray Liu | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV† |
| 000536 |
M. Bizzarri [Italie] ; A S Laganà ; D. Aragona ; V. Unfer | Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2? |
| 000560 |
Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie] | In Silico Discovery of Candidate Drugs against Covid-19. |
| 000580 |
Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine] | Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. |
| 000587 |
Heidi Ledford | How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments. |
| 000648 |
Marco Malavolta [Italie] ; Robertina Giacconi [Italie] ; Dario Brunetti [Italie] ; Mauro Provinciali [Italie] ; Fabrizio Maggi [Italie] | Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats. |
| 000658 |
Iek Long Lo [République populaire de Chine] ; Chon Fu Lio [République populaire de Chine] ; Hou Hon Cheong [République populaire de Chine] ; Chin Ion Lei [République populaire de Chine] ; Tak Hong Cheong [République populaire de Chine] ; Xu Zhong [République populaire de Chine] ; Yakun Tian [République populaire de Chine] ; Nin Ngan Sin [République populaire de Chine] | Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau |
| 000713 |
Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000722 |
Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine] | Discovering drugs to treat coronavirus disease 2019 (COVID-19). |
| 000746 |
Dae-Gyun Ahn [Corée du Sud] ; Hye-Jin Shin [Corée du Sud] ; Mi-Hwa Kim [Corée du Sud] ; Sunhee Lee [Corée du Sud] ; Hae-Soo Kim [Corée du Sud] ; Jinjong Myoung [Corée du Sud] ; Bum-Tae Kim [Corée du Sud] ; Seong-Jun Kim [Corée du Sud] | Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). |
| 000747 |
Md Insiat Islam Rabby [Malaisie] | Current Drugs with Potential for Treatment of COVID-19: A Literature Review. |
| 000774 |
Daniela Ruffell | Coronavirus SARS‐CoV‐2: filtering fact from fiction in the infodemic |
| 000795 |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
| 000817 |
Francine Touzard-Romo [États-Unis] ; Chantal Tapé [États-Unis] ; John R. Lonks [États-Unis] | Co-infection with SARS-CoV-2 and Human Metapneumovirus. |
| 000823 |
Taisheng Li [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] ; Wenhong Zhang [République populaire de Chine] | Clinical observation and management of COVID-19 patients. |
| 000846 |
Philippe Colson [France] ; Jean-Marc Rolain [France] ; Didier Raoult [France] | Chloroquine for the 2019 novel coronavirus SARS-CoV-2 |
| 000883 |
Hui Luo [République populaire de Chine] ; Qiao-Ling Tang [République populaire de Chine] ; Ya-Xi Shang [République populaire de Chine] ; Shi-Bing Liang [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Nicola Robinson [République populaire de Chine] ; Jian-Ping Liu [République populaire de Chine] | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs |
| 000889 |
Kamal Kant Sahu [Oman] ; Ajay Kumar Mishra [Oman] ; Amos Lal [Oman] | COVID-2019: update on epidemiology, disease spread and management. |
| 000923 |
Paola Rizzo [Italie] ; Francesco Vieceli Dalla Sega [Italie] ; Francesca Fortini [Italie] ; Luisa Marracino [Italie] ; Claudio Rapezzi [Italie] ; Roberto Ferrari [Italie] | COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? |
| 000935 |
Hrvoje Jakovac [Croatie] | COVID-19 and vitamin D-Is there a link and an opportunity for intervention? |
| 000964 |
Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine] | Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. |
| 000967 |
Valentina Spezzani [Italie] ; Alessio Piunno [Italie] ; Hans-Ulrich Iselin [Suisse] | Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple. |
| 000979 |
Ahmad Alimadadi [États-Unis] ; Sachin Aryal [États-Unis] ; Ishan Manandhar [États-Unis] ; Patricia B. Munroe [États-Unis] ; Bina Joe [États-Unis] ; Xi Cheng [États-Unis] | Artificial intelligence and machine learning to fight COVID-19. |
| 000991 |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| 000A45 |
Yung-Fang Tu [Taïwan] ; Chian-Shiu Chien [Taïwan] ; Aliaksandr A. Yarmishyn [Taïwan] ; Yi-Ying Lin [Taïwan] ; Yung-Hung Luo [Taïwan] ; Yi-Tsung Lin [Taïwan] ; Wei-Yi Lai [Taïwan] ; De-Ming Yang [Taïwan] ; Shih-Jie Chou [Taïwan] ; Yi-Ping Yang [Taïwan] ; Mong-Lien Wang [Taïwan] ; Shih-Hwa Chiou [Taïwan] | A Review of SARS-CoV-2 and the Ongoing Clinical Trials. |
| 000B15 |
Piercarlo Sarzi-Puttini [Italie] ; Valeria Giorgi [Italie] ; Silvia Sirotti [Italie] ; Daniela Marotto [Italie] ; Sandro Ardizzone [Italie] ; Giuliano Rizzardini [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
